GB0400988D0 - Therapeutically useful antibacterial compounds - Google Patents

Therapeutically useful antibacterial compounds

Info

Publication number
GB0400988D0
GB0400988D0 GBGB0400988.2A GB0400988A GB0400988D0 GB 0400988 D0 GB0400988 D0 GB 0400988D0 GB 0400988 A GB0400988 A GB 0400988A GB 0400988 D0 GB0400988 D0 GB 0400988D0
Authority
GB
United Kingdom
Prior art keywords
therapeutically useful
antibacterial compounds
useful antibacterial
compounds
therapeutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0400988.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxoid Ltd
Original Assignee
Oxoid Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxoid Ltd filed Critical Oxoid Ltd
Priority to GBGB0400988.2A priority Critical patent/GB0400988D0/en
Publication of GB0400988D0 publication Critical patent/GB0400988D0/en
Priority to PCT/GB2005/000131 priority patent/WO2005067939A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6903Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being semi-solid, e.g. an ointment, a gel, a hydrogel or a solidifying gel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6943Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GBGB0400988.2A 2004-01-16 2004-01-16 Therapeutically useful antibacterial compounds Ceased GB0400988D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0400988.2A GB0400988D0 (en) 2004-01-16 2004-01-16 Therapeutically useful antibacterial compounds
PCT/GB2005/000131 WO2005067939A1 (en) 2004-01-16 2005-01-17 Therapeutically useful antibacterial compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0400988.2A GB0400988D0 (en) 2004-01-16 2004-01-16 Therapeutically useful antibacterial compounds

Publications (1)

Publication Number Publication Date
GB0400988D0 true GB0400988D0 (en) 2004-02-18

Family

ID=31726312

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0400988.2A Ceased GB0400988D0 (en) 2004-01-16 2004-01-16 Therapeutically useful antibacterial compounds

Country Status (2)

Country Link
GB (1) GB0400988D0 (en)
WO (1) WO2005067939A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69504973T2 (en) * 1994-06-10 1999-02-18 Dumex Ltd As SALES OF MEDICATIONS
GB2323089B (en) * 1996-04-12 1999-02-10 Lovesgrove Res Ltd Method for preparing organo phosphonic compounds
DE10014127A1 (en) * 2000-03-22 2001-10-18 Hassan Jomaa Antibacterial, fungicidal, antiviral, antiparasitic and herbicidal agents for medicinal, veterinary or agricultural use, comprising amino- or imino-substituted organophosphorus compounds having nitrogen-containing spacer group
GB0022556D0 (en) * 2000-09-14 2000-11-01 Oxoid Ltd Improvements in or relating to selective agents for biological cultures
AU2002251448A1 (en) * 2001-04-01 2002-10-15 Yeda Research And Development Co. Ltd. Weizmann Institute Of Science Oral absorbed drugs

Also Published As

Publication number Publication date
WO2005067939A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
EP1796466A4 (en) Antibacterial agents
EP1718638A4 (en) Novel compounds
EP1773343A4 (en) Antibacterial agents
GB0400812D0 (en) Novel compounds
EP1784410A4 (en) Antibacterial agents
GB0419694D0 (en) Anti-bacterial compounds
GB0402140D0 (en) Novel compounds
EP1805132A4 (en) Novel compounds
EP1796793A4 (en) Novel compounds
GB0402357D0 (en) Novel compounds
GB0314488D0 (en) Therapeutically useful compounds
EP1827449A4 (en) The use of novel antibacterial compounds
GB0407861D0 (en) Antibacterial agents
GB0402355D0 (en) Novel compounds
GB0402812D0 (en) Novel compounds
GB0419693D0 (en) Anti-bacterial compounds
GB0402356D0 (en) Novel compounds
GB0319069D0 (en) Therapeutically useful compounds
GB0400988D0 (en) Therapeutically useful antibacterial compounds
GB0404105D0 (en) Novel compounds
GB0402380D0 (en) Novel compounds
GB0411351D0 (en) Antibacterial compounds
GB0321108D0 (en) Therapeutically useful compounds
GB0320988D0 (en) Therapeutically useful compounds
GB0413813D0 (en) Antibacterial agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)